APLT Stock Analysis: Buy, Sell, or Hold?
APLT - Applied Therapeutics, Inc. Common Stock
$0.10
0.00 (0.19%)
â˛
5d:
+6.96%
30d:
+3.0%
90d:
-90.88%
WAIT
LOW Confidence
Analysis Updated: Feb 2, 2026 12:00 AM ET
Earnings: Mar 13, 2026
0d
Get Alerted When APLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: APLT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: APLT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: APLT is currently trading at $0.10, which is considered fair based on recent price action.
Technical Outlook: Technically, APLT is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $0.11.
Market Sentiment: APLT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $0.25 (+142.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APLT is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $0.11.
Market Sentiment: APLT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $0.25 (+142.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 142.7% below Wall St target ($0.25)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.09
Resistance Level
$0.11
Current Trend
Strong Uptrend
Technical data as of
Feb 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.26
Wall Street Target
$0.25
(+142.7%)
Revenue Growth (YoY)
719.7%
Share & Embed Analysis
Last updated: August 26, 2026 4:23 AM ET
Data refreshes hourly during market hours. Next update: 5:23 AM
Data refreshes hourly during market hours. Next update: 5:23 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 38 SELL |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 39 SELL |
